[{"address1": "7800 Susquehanna St.", "address2": "Suite 505", "city": "Pittsburgh", "state": "PA", "zip": "15208", "country": "United States", "phone": "412 894 1853", "website": "https://lipella.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan  Kaufman M.B.A., Ph.D.", "age": 58, "title": "Co-Founder, Chairman, CEO, President, Secretary & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 233300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael B. Chancellor M.D.", "age": 66, "title": "Co-Founder, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 225000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Douglas  Johnston CPA", "age": 39, "title": "Chief Financial Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 165000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michele  Gruber", "title": "Director of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Janet  Okonski", "title": "Director of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Katie  Johnston", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.53, "open": 0.54, "dayLow": 0.54, "dayHigh": 0.54, "regularMarketPreviousClose": 0.53, "regularMarketOpen": 0.54, "regularMarketDayLow": 0.54, "regularMarketDayHigh": 0.54, "payoutRatio": 0.0, "beta": -0.077, "forwardPE": -0.16875, "volume": 1000, "regularMarketVolume": 1000, "averageVolume": 9315, "averageVolume10days": 20620, "averageDailyVolume10Day": 20620, "bid": 0.542, "ask": 0.567, "bidSize": 2000, "askSize": 1000, "marketCap": 2495252, "fiftyTwoWeekLow": 0.315, "fiftyTwoWeekHigh": 7.31, "allTimeHigh": 61.76, "allTimeLow": 0.315, "priceToSalesTrailing12Months": 5.307206, "fiftyDayAverage": 0.54958, "twoHundredDayAverage": 1.64792, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12021, "profitMargins": 0.0, "floatShares": 4329355, "sharesOutstanding": 4620837, "sharesShort": 100093, "sharesShortPriorMonth": 133447, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0224, "heldPercentInsiders": 0.06525, "heldPercentInstitutions": 0.0135, "shortRatio": 3.32, "shortPercentOfFloat": 0.0235, "impliedSharesOutstanding": 4620838, "bookValue": 0.614, "priceToBook": 0.8794788, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -5520318, "trailingEps": -3.33, "forwardEps": -3.2, "lastSplitFactor": "1:8", "lastSplitDate": 1731024000, "enterpriseToRevenue": -0.026, "enterpriseToEbitda": 0.002, "52WeekChange": -0.77056277, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 0.54, "recommendationKey": "none", "totalCash": 2781828, "totalCashPerShare": 0.602, "ebitda": -5592217, "totalDebt": 274539, "quickRatio": 3.781, "currentRatio": 4.602, "totalRevenue": 470163, "debtToEquity": 10.014, "revenuePerShare": 0.216, "returnOnAssets": -1.18454, "returnOnEquity": -2.4835699, "grossProfits": -3423922, "freeCashflow": -2477698, "operatingCashflow": -4502780, "revenueGrowth": -0.364, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.641899, "financialCurrency": "USD", "symbol": "LIPO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "corporateActions": [], "regularMarketTime": 1763154000, "exchange": "PNK", "messageBoardId": "finmb_35907207", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Lipella Pharmaceuticals Inc.", "longName": "Lipella Pharmaceuticals Inc.", "fiftyDayAverageChange": -0.0095799565, "fiftyDayAverageChangePercent": -0.017431416, "twoHundredDayAverageChange": -1.1079199, "twoHundredDayAverageChangePercent": -0.67231417, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-12-20", "cryptoTradeable": false, "regularMarketChangePercent": 1.886802, "regularMarketPrice": 0.54, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1671460200000, "regularMarketChange": 0.01000005, "regularMarketDayRange": "0.54 - 0.54", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 9315, "fiftyTwoWeekLowChange": 0.22500002, "fiftyTwoWeekLowChangePercent": 0.7142858, "fiftyTwoWeekRange": "0.315 - 7.31", "fiftyTwoWeekHighChange": -6.77, "fiftyTwoWeekHighChangePercent": -0.92612857, "fiftyTwoWeekChangePercent": -77.056274, "epsTrailingTwelveMonths": -3.33, "epsForward": -3.2, "displayName": "Lipella Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]